Next Article in Journal
Remote Monitoring of Cardiac Implantable Electronic Devices in Very Elderly Patients: Advantages and Specific Problems
Previous Article in Journal
Machine Learning Approaches for Stroke Risk Prediction: Findings from the Suita Study
Previous Article in Special Issue
Is Conduction System Pacing a Valuable Alternative to Biventricular Pacing for Cardiac Resynchronization Therapy?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy

Department of Medicine and Hematology, Semmelweis University, Szentkirályi u. 46, 1088 Budapest, Hungary
J. Cardiovasc. Dev. Dis. 2024, 11(7), 208; https://doi.org/10.3390/jcdd11070208
Submission received: 7 June 2024 / Revised: 22 June 2024 / Accepted: 27 June 2024 / Published: 3 July 2024
Although cardiac resynchronization therapy (CRT) is an evidence-based effective therapy of symptomatic heart failure with reduced ejection fraction (HFrEF), refractory to optimal medical treatment and associated with intraventricular conduction disturbance, the non-response rate to CRT is still around 30%. In patients with HFrEF, intraventricular conduction disturbance results in electrical ventricular dyssynchrony, which further deteriorates systolic ventricular function. The main determinant of CRT outcome is the presence or absence of significant ventricular electrical dyssynchrony (which results in ventricular mechanical dyssynchrony) and the ability of the applied CRT technique to eliminate it [1,2]. CRT is not effective in mechanical ventricular dyssynchrony without electrical dyssynchrony (e.g., that occurs in the presence of myocardial scar or myocarditis); it can only eliminate mechanical dyssynchrony due to underlying primary electrical ventricular dyssynchrony [3]. Therefore, theoretically, electrocardiological and electrophysiological criteria are probably more important in patient selection for CRT than imaging criteria. The current guidelines [4] recommending only QRS duration and morphology for patient selection for CRT and not recommending imaging modality criteria after the disappointing results of the PROSPECT trial [5], investigating the role of echocardiographic mechanical dyssynchrony criteria for patient selection for CRT, comply with this principle. However, there may be two main reasons for the still non-negligible non-response rate to CRT. The first reason is that QRS duration and morphology are not optimal criteria to assess the presence or absence of ventricular electrical dyssynchrony. The second reason is that the current biventricular pacing CRT (BIVP-CRT) technique, using apical right ventricular (RV) and epicardial left ventricular (LV) pacing in the posterolateral or lateral area, although significantly improving ventricular dyssynchrony and resulting in a more synchronious ventricular activation, cannot completely restore the physiological ventricular activation and synchrony [6]. Another problematic property of the current BIVP-CRT technique is that it was originally devised to eliminate dyssynchrony caused by left bundle branch block (LBBB) pattern. It is not appropriate in patients with pure, typical right bundle branch block (RBBB) pattern, and may not be appropriate in some patients with nonspecific intraventricular conduction disturbance (NICD) pattern, for eliminating dyssynchrony. This is because the latest activated LV site in patient with pure, typical RBBB and in some patients with NICD patterns is far away from the standard LV pacing site used in the BIVP-CRT technique [2]. Therefore, we can decrease the non-response rate to CRT if we can apply better pre-CRT patient selection criteria than QRS duration and morphology, that can more accurately assess the presence or absence of significant ventricular electrical dyssynchrony. The other possible way to decrease the non-response rate to CRT is the application of novel CRT techniques, such as conduction system pacing (CSP) [His bundle pacing (HBP) and left bundle branch area pacing (LBBAP)]. These, in contrast to BIVP-CRT technique, can completely restore physiological ventricular activation [6]. Another possibility to reduce the number of non-responders to CRT is to apply an individualized BIVP-CRT technique, when the LV pacing electrode is positioned at the site or very close to the site of the latest activated LV region [7]. Another advantage of CSP compared with BIVP-CRT technique is that the latter has proarrhythmic potential due to non-physiologic ventricular activation. In contrast to that, CSP potentially abolishes this proarrhythmic effect by restoring physiological ventricular activation [6]. This Special Issue, under the title “New pacing techniques and non-invasive methods that may improve response and patient selection to cardiac resynchronization therapy”, discusses novel non-invasive techniques and methods that can better assess the presence of ventricular electrical dyssynchrony than QRS duration and morphology and provides a review of CSP.
Simon A et al., (contribution 1) discuss novel 12-lead ECG signs that may improve the prediction of response to CRT, such as the presence of masquerading bundle branch block, the higher R wave amplitude and R/S ratio in lead V6 [8], increased intrinsicoid deflection (ID) in lateral leads [9], the novel intraventricular [(aVLID-aVFID)/QRS duration] and interventricular [(V5ID − V1ID)/QRS duration] ECG dyssynchrony criteria > 25% [10], and a QRmax index ≥ 120 ms, that is the longest QR index in the limb leads, which is the interval from the onset of the QRS to the R wave offset, defined as the intersection between the descending limb of the R wave and the baseline [11]. They also delineate that a Q-LV interval > 95 ms, measured during CRT from the onset of the QRS on the 12-lead ECG to the first large peak of the LV electrogram obtained from the LV pacing lead, predicts response to CRT as well [12]. An RV-LV interval ≥ 70 ms, determined during unpaced beats during CRT by measuring the interval between the first large positive or negative peaks of the RV and LV electrograms, also predicts response to CRT [13].
Eerenberg F et al., (contribution 2) discuss the potential use of the vectorcardiographic QRS area in pre-CRT patient selection and in LV lead implantation guidance during CRT. A QRS area > 109 μVs predicts a response to CRT, and a greater reduction in QRS area during CRT indicates a more optimal position of the LV electrode [14].
Abu-Alrub S et al., (contribution 3) summarize the role of electrocardiographic imaging, a combination of body surface mapping with computed tomography and a special software, which corresponds to a non-invasive epicardial electrophysiological examination, in patient selection for CRT and the optimization of LV lead placement, and the possible use of ECG belt, an innovative body surface mapping system, in patient selection for CRT.
Nguyen UC et al., (contribution 4) outline the clinical application of ultra-high-frequency ECG (UHF-ECG) in dyssynchrony assessment for patient selection to CRT and during cardiac pacing to show which pacing modality preserves best ventricular synchrony. UHF-ECG displays the ventricular activation sequence analyzing the ultra-high-frequency (150–1000 Hz) components of ventricular myocyte action potentials’depolarization phase (phase 0) using either the standard chest leads (V1–V6) or 8 chest leads (V1–V8).
The above-mentioned promising methods—vectorcardiographic QRS area, electrocardiographic imaging, ECG belt and UHF-ECG—can decrease non-response to CRT by providing a more accurate assessment of ventricular electrical dyssynchrony than QRS duration and morphology.
Dutta et al., (contribution 5) describe the most promising echocardiographic mechanical dyssynchrony parameters that can be applied after the disappointing PROSPECT trial for better patient selection for CRT, mostly in patients with non-LBBB pattern, who respond less well to CRT, but also in patients with LBBB pattern. These potentially valuable echocardiographic dyssynchrony parameters that can identify CRT responders are as follows: (1) the mechanical dispersion index (standard deviation of the averaged time to peak longitudinal strain) ≥ 60 ms, (2) the time difference in peak septal wall to posterior wall radial strain ≥ 130 ms, (3) the presence of apical rocking, (4) the presence of septal flash, and (5) the classical pattern of mechanical discoordination in patients with LBBB pattern (early contraction of septal wall and simultaneous passive stretching of the opposite lateral wall, which contracts late, achieving its peak contraction after aortic valve closure).The estimation of myocardial work, which is a more sensitive, afterload-independent parameter of LV systolic function and ventricular dyssynchrony than the afterload-dependent ejection fraction and global longitudinal strain, is also a promising parameter to predict response to CRT [15,16]. The results of the Markers and Response to CRT (MARC) study [17] support that one previously mentioned echocardiographic parameter and the vectorcardiographic QRS area are potentially valuable in the identification of CRT responders, because they found that independent predictors of CRT response [defined as a ≥15% reduction of LV end systolic volume (LVESV)] were as follows: younger age (<60 years); larger QRS area; longer interventricular mechanical delay (>40 ms); calculated as the difference between LV and RV pre-ejection intervals; measured from the QRS complex to the onset of aortic and pulmonic flow; and the presence of apical rocking.
Cano O et al., (contribution 6) and Castagno D et al., (contribution 7) discuss CSP (HBP and LBBAP) in detail, which is gradually becoming a potential real alternative to the standard BIVP-CRT technique due to its ability to restore the physiologic ventricular activation.

Conflicts of Interest

The author declares no conflicts of interest.

List of Contributions

  • Simon, A.; Pilecky, D.; Kiss, L.Z.; Vamos, M. Useful electrocardiographic signs to support the prediction of favorable response to cardiac resynchronization therapy. J. Cardiovasc. Dev. Dis. 2023, 10, 425. https://doi.org/10.3390/jcdd10100425.
  • Eerenberg, F.; Luermans, J.; Lumens, J.; Nguyen, U.C.; Vernooy, K.; van Stipdonk, A. Exploring QRS area beyond patient selection in CRT-Can it guide left ventricular lead placement? J. Cardiovasc. Dev. Dis. 2024, 11, 18. https://doi.org/10.3390/jcdd11010018.
  • Abu-Alrub, S.; Strik, M.; Huntjens, P.; Haïssaguerre, M.; Eschalier, R.; Bordachar, P.; Ploux, S. Current Role of Electrocardiographic Imaging in Patient Selection for Cardiac Resynchronization Therapy. J. Cardiovasc. Dev. Dis. 2024, 11, 24. https://doi.org/10.3390/jcdd11010024.
  • Nguyên, U.C.; Rijks, J.H.J.; Plesinger, F.; Rademakers, L.M.; Luermans, J.; Smits, K.C.; van Stipdonk, A.M.W.; Prinzen, F.W.; Vernooy, K.; Halamek, J.; et al. Ultra-High-Frequency ECG in Cardiac Pacing and Cardiac Resynchronization Therapy: From Technical Concept to Clinical Application. J. Cardiovasc. Dev. Dis. 2024, 11, 76. https://doi.org/10.3390/jcdd11030076.
  • Dutta, A.; Alqabbani, R.R.M.; Hagendorff, A.; Tayal, B. Understanding the Application of Mechanical Dyssynchrony in Patients with Heart Failure Considered for CRT. J. Cardiovasc. Dev. Dis. 2024, 11, 64. https://doi.org/10.3390/jcdd11020064.
  • Cano, Ó.; Navarrete-Navarro, J.; Jover, P.; Osca, J.; Izquierdo, M.; Navarro, J.; Ayala, H.D.; Martínez-Dolz, L. Conduction System Pacing for Cardiac Resynchronization Therapy. J. Cardiovasc. Dev. Dis. 2023, 10, 448. https://doi.org/10.3390/jcdd10110448.
  • Castagno, D.; Zanon, F.; Pastore, G.; De Ferrari, G.M.; Marcantoni, L. Is Conduction System Pacing a Valuable Alternative to Biventricular Pacing for Cardiac Resynchronization Therapy? J. Cardiovasc. Dev. Dis. 2024, 11, 144. https://doi.org/10.3390/jcdd11050144.

References

  1. Nguyen, U.C.; Vernooy, K.; Prinzen, F.W. Quest for the ideal assessment of electrical ventricular dyssynchrony in cardiac resynchronization therapy. J. Mol. Cell. Cardiol. Plus 2024, 7, 100061. [Google Scholar] [CrossRef]
  2. Katona, G.; Vereckei, A. Novel electrocardiographic dyssynchrony criteria that may improve patient selection for cardiac resynchronization therapy. J. Geriat. Cardiol. 2022, 19, 31–43. [Google Scholar]
  3. Gorcsan, J., III; Sogaard, P.; Bax, J.J.; Singh, J.P.; Abraham, W.T.; Borer, J.S.; Dickstein, K.; Gras, D.; Krum, H.; Brugada, J.; et al. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: A subgroup analysis of the EchoCRT trial. Eur. Heart J. 2016, 37, 49–59. [Google Scholar] [CrossRef] [PubMed]
  4. Glikson, M.; Nielsen, J.C.; Kronborg, M.B.; Michowitz, Y.; Auricchio, A.; Barbash, I.M.; Barrabes, J.A.; Boriani, G.; Braunschweig, F.; Brignole, M.; et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 2021, 42, 3427–3520. [Google Scholar] [PubMed]
  5. Bax, J.J.; Gorcsan, J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: Results of the PROSPECT [Predictors of Response to Cardiac Resynchronization Therapy] study in perspective. J. Am. Coll. Cardiol. 2009, 53, 1933–1943. [Google Scholar] [CrossRef]
  6. Herweg, B.; Welter-Frost, A.; Wilson, D.R.; Vijayaraman, P. Conduction system pacing for cardiac resynchronization therapy. Card. Electrophysiol. Clin. 2022, 14, 297–310. [Google Scholar] [CrossRef]
  7. Parreira, L.; Tsyganov, A.; Artyukhina, E.; Vernooy, K.; Tondo, C.; Adragao, P.; Ascione, C.; Carmo, P.; Carvalho, S.; Egger, M.; et al. Non-invasive three-dimensional electrical activation mapping to predict cardiac resynchronization therapy response: Site of latest left ventricular activation relative to pacing site. Europace 2023, 25, 1458–1466. [Google Scholar] [CrossRef]
  8. Poposka, L.; Boskov, V.; Risteski, D.; Taleski, J.; Janusevski, F.; Srbinovska, E.; Georgievska-Ismail, L. Electrocardiographic parameters as predictors of response to cardiac resynchronization therapy. Open Access Maced. J. Med. Sci. 2018, 6, 297–302. [Google Scholar] [CrossRef]
  9. Del-Carpio Munoz, F.; Powell, B.D.; Cha, Y.-M.; Wiste, H.J.; Redfield, M.M.; Friedman, P.A.; Asirvatham, S.J. Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy. Heart Rhythm. 2013, 10, 979–987. [Google Scholar] [CrossRef]
  10. Vereckei, A.; Szelényi, Z.; Kutyifa, V.; Zima, E.; Szénási, G.; Kiss, M.; Katona, G.; Karádi, I.; Merkely, B. Novel electrocardiographic dyssynchrony criteria improve patient selection for cardiac resynchronization therapy. Europace 2018, 20, 97–103. [Google Scholar] [CrossRef] [PubMed]
  11. Pastore, G.; Maines, M.; Marcantoni, L.; Lanza, D.; Zanon, F.; Noventa, F.; Corbucci, G.; Rigatelli, G.; Baracca, E.; Zuin, M.; et al. The QR-max index, a novel electrocardiographic index for the determination of left ventricular conduction delay and selection of cardiac resynchronization in patients with non-left bundle branch block. J. Interv. Card. Electrophysiol. 2020, 58, 147–156. [Google Scholar] [CrossRef] [PubMed]
  12. Gold, M.R.; Birgersdotter-Green, U.; Singh, J.P.; Ellenbogen, K.A.; Yu, Y.; Meyer, T.E.; Seth, M.; Tchou, P.J. The relationship between ventricular electrical delay and left ventricular remodeling with cardiac resynchronization therapy. Eur. Heart J. 2011, 32, 2516–2524. [Google Scholar] [CrossRef] [PubMed]
  13. Field, M.E.; Yu, N.; Wold, N.; Gold, M.R. Comparison of measures of ventricular delay on cardiac resynchronization therapy response. Heart Rhythm. 2020, 17, 615–620. [Google Scholar] [CrossRef] [PubMed]
  14. van Stipdonk, A.M.W.; ter Horst, I.; Kloosterman, M.; Engels, E.B.; Rienstra, M.; Crijns, H.J.G.M.; Vos, M.A.; van Gelder, I.C.; Prinzen, F.W.; Meine, M.; et al. QRS area is a strong determinant of outcome in cardiac resynchronization therapy. Circ. Arrhythm. Electrophysiol. 2018, 11, e006497. [Google Scholar] [CrossRef]
  15. Sperlongano, S.; Benfari, G.; Ilardi, F.; Lisi, M.; Malagoli, A.; Mandoli, G.E.; Pastore, M.C.; Mele, D.; Cameli, M.; D’Andrea, A. Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy. Int. J. Cardiol. 2024, 402, 131885. [Google Scholar] [CrossRef] [PubMed]
  16. Smiseth, O.; Donal, E.; Penicka, M.; Sletten, O.J. How to measure left ventricular myocardial work by pressure-strain loops. Eur. Heart J.-Cardiovasc. Imaging 2021, 22, 259–261. [Google Scholar] [CrossRef] [PubMed]
  17. Maass, A.H.; Vernooy, K.; Wijers, S.C.; van’t Sant, J.; Cramer, M.J.; Meine, M.; Allaart, C.P.; De Lange, F.J.; Prinzen, F.W.; Gerritse, B.; et al. Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodeling: Results from the Markers and Response to CRT (MARC) study. Europace 2018, 20, e1–e10. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vereckei, A. New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy. J. Cardiovasc. Dev. Dis. 2024, 11, 208. https://doi.org/10.3390/jcdd11070208

AMA Style

Vereckei A. New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy. Journal of Cardiovascular Development and Disease. 2024; 11(7):208. https://doi.org/10.3390/jcdd11070208

Chicago/Turabian Style

Vereckei, András. 2024. "New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy" Journal of Cardiovascular Development and Disease 11, no. 7: 208. https://doi.org/10.3390/jcdd11070208

APA Style

Vereckei, A. (2024). New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy. Journal of Cardiovascular Development and Disease, 11(7), 208. https://doi.org/10.3390/jcdd11070208

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop